Valuation: Clover Corporation Limited

Market Cap 169M 119M 106M 97.81M 88.63M 166M 11.25B 1.18B 466M 5.9B 445M 435M 18.59B P/E 2027 *
12.4x
P/E 2028 * 9.95x
Enterprise Value 154M 108M 96.83M 89.45M 81.06M 152M 10.29B 1.08B 426M 5.39B 407M 398M 17B EV / Sales 2027 *
1.34x
EV / Sales 2028 * 1.09x
Free-Float
75.83%
Yield 2027 *
2.22%
Yield 2028 * 2.22%
1 day-2.96%
1 week-4.37%
Current month-5.74%
1 month-1.50%
3 months+5.35%
6 months-1.50%
Current year+24.68%
1 week 0.98
Extreme 0.98
1.05
1 month 0.95
Extreme 0.95
1.11
Current year 0.7
Extreme 0.7
1.16
1 year 0.62
Extreme 0.62
1.16
3 years 0.34
Extreme 0.337
1.16
5 years 0.34
Extreme 0.337
1.8
10 years 0.34
Extreme 0.337
3.31
Manager TitleAgeSince
Chief Executive Officer - 10/11/2014
Director of Finance/CFO - 05/05/2021
Chief Operating Officer - 02/02/2011
Director TitleAgeSince
Director/Board Member - 10/11/2014
Chairman - 20/09/2017
Director/Board Member - 31/01/2017
Date Insider Type Main position Quantity % Market Cap. Importance
18/11/25 Sell

Chief Executive Officer

255,199 0.1528%
18/11/25 Buy

Chief Executive Officer

529,638 0.3171%
06/11/25 Buy

Chief Financial Officer

2,447 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
-2.96%-4.37%+56.35%+8.24% 119M
-0.79%+1.54%+4.48%-15.07% 261B
-2.13%-0.17%+4.99%-2.87% 81.43B
+3.29%-0.04%+45.39%+549.46% 46.32B
-0.22%+1.10%-19.98%+13.43% 44.84B
+0.38%-2.99%+26.54%+12.79% 38.62B
-3.42%-0.70%-5.43%-12.77% 34.09B
-1.07%-4.77%+17.10%+81.17% 30.83B
+3.17%-0.26%-10.54%-1.48% 29.7B
-1.16%+4.73%-1.78%-22.69% 29.41B
Average -0.49%-0.18%+11.71%+61.02% 59.63B
Weighted average by Cap. -0.52%+0.47%+6.36%+39.80%

Financials

2027 *2028 *
Net sales 115M 80.85M 72.2M 66.7M 60.44M 113M 7.67B 803M 318M 4.02B 303M 297M 12.68B 132M 92.77M 82.84M 76.53M 69.35M 130M 8.81B 921M 365M 4.61B 348M 341M 14.55B
Net income 13.7M 9.64M 8.6M 7.95M 7.2M 13.48M 915M 95.66M 37.87M 479M 36.16M 35.39M 1.51B 17M 11.96M 10.68M 9.86M 8.94M 16.72M 1.14B 119M 46.99M 595M 44.87M 43.92M 1.87B
Net Debt -14.4M -10.13M -9.04M -8.36M -7.57M -14.17M -961M -101M -39.81M -504M -38.01M -37.2M -1.59B -24.9M -17.51M -15.64M -14.45M -13.09M -24.49M -1.66B -174M -68.83M -871M -65.72M -64.33M -2.75B
Projected Income Statement - Annual - Clover Corporation Limited
Logo Clover Corporation Limited
Clover Corporation Limited focused on technology, new product development, and commercialization. The principal activities of the Company are the refining and sale of natural oils, the production of encapsulated powders and the research and product development of functional food and infant nutrition ingredients. Its microencapsulation technology enables nutritional oils, such as tuna, fish, algal and fungal oils, to be added to infant formulas, foods, and beverages. Its technologies protect those sensitive oils from oxidation, allowing them to be incorporated into a range of applications. The Company, through its subsidiary, Nu-Mega Ingredients Pty Limited (Nu-Mega), supplies refined Omega-3 oils and a range of other encapsulated ingredients for use in infant formula, nutraceuticals, pharmaceuticals, and sports nutrition markets. Nu-Mega’s Driphorm range of microencapsulated powders enables the addition of Hi-DHA tuna and/or algal oils to a broad spectrum of products.
Employees
81
Date Price Change Volume
26/10/26 A$0.9850 -2.96% 431,332
23/10/26 A$1.015 -0.49% 251,217
22/10/26 A$1.020 -0.49% 112,483
21/10/26 A$1.025 -2.38% 138,833
20/10/26 A$1.050 +1.94% 143,580
Trader
Investor
Global
Quality
ESG MSCI
BB
MarketScreener Ratings - Clover Corporation Limited
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
1.015AUD
Average target price
1.315AUD
Spread / Average Target
+29.56%

Annual profits - Rate of surprise

Rate of surprise - EPS - Annual - Clover Corporation Limited